克拉霉素联合兰索拉唑治疗幽门螺杆菌感染性胃病的临床疗效观察

The Clinical Efficacy of Clarithromycin Combined With Lansoprazole Treatment of Helicobacter Pylori Infection of the Stomach

目的对克拉霉素与兰索拉唑联合用于幽门螺杆菌感染性胃病治疗中的临床疗效进行探究。方法将我院收治的84例幽门螺杆菌感染性胃病患者随机分为观察组(42例)与对照组(42例),以常规方法对对照组患者进行治疗,以克拉霉素+兰索拉唑对观察组患者进行治疗,并对两组患者治疗后的总有效率及幽门螺杆菌清除率进行比较。结果经治疗后,观察组患者的总有效率及幽门螺杆菌清除率分别为95.24%、90.48%,与对照组相比效果较好,差异具有统计学意义(P<0.05)。结论对幽门螺杆菌感染性胃病患者以克拉霉素+兰索拉唑可取得较为良好的治疗效果。

Objective Clarithromycin and lansoprazole joint for the treatment of helicobacter pylori infection of the stomach to explore clinical efficacy. Methods 84 cases of stomach helicobacter pylori infection were randomly divided into observation group（42 cases） and control group（42 cases）, in a conventional method for the control group of patients treated with clarithromycin and lansoprazole to observe patients for treatment, and the total efficiency of the two groups of patients and Helicobacter pylori clearance after treatment were compared. Results After treatment, the observation group of patients with total efficiency and Helicobacter pylori eradication rates were 95.24%, 90.48%, compared with the control group was significantly superior, the difference was statistically significant（P〈0.05）. Conclusion Helicobacter pylori infection of the stomach in patients with clarithromycin and lansoprazole may obtain a more favorable therapeutic effect.